Antinuclear antibodies by indirect immunofluorescence: Optimum screening dilution for diagnosis of systemic lupus erythematosus

Indian Journal of Medical Research

Volumn 126, Issue 1, 2007, Pages 34-38

  Ghosh, P ^a   Dwivedi, S ^a   Naik, Sita ^a   Agarwal, Vikas ^a   Verma, Anupam ^a   Aggarwal, Amita ^a   Misra, Ramnath ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Antinuclear antibodies; Indirect immunofluorescence; Screening dilutions; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DERMATOMYOSITIS; DIAGNOSTIC VALUE; DILUTION; FEMALE; FLUORESCENCE ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; POLYMYOSITIS; RECEIVER OPERATING CHARACTERISTIC; RHEUMATOID ARTHRITIS; SCREENING TEST; SEROLOGY; SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; ADOLESCENT; BLOOD; FLUORESCENT ANTIBODY TECHNIQUE; METHODOLOGY; MIDDLE AGED; ROC CURVE;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTINUCLEAR; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; ROC CURVE;

EID: 35548956810     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Holbrow EJ, Weir DM, Jhonson GD. A serum factor in lupus erythematosus with affinity for tissue nuclei. Br Med J 1957; 2: 732-4.
2. Lipscomb MF, Cope LD, Stephens GL, Deng JS, Gilliam JN. Comparison of substrates for the detection of antinuclear antibodies in normals and in patients with connective tissue and other diseases. Diagn Immunol 1984; 2: 181-7.
3. Von Muhlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 1998; 41: 1152-60.
4. Hooper B, Whittingham S, Mathews JD, Machay IR, Crunow DH. Autoimmunity in a rural community. Clin Exp Immunol 1972; 12: 79-87.
5. Cainelli F, Betterle C, Vento S. Antinuclear antibodies are common in an infectious environment but do not predict sistemic lupus erythematosus. Ann Rheum Dis 2004; 63: 1707-8.
6. Hoschberg MC. Updating the ACR revised criteria for the classification of SLE. Arthritis Rheum 1997; 40: 1725.
7. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975; 292: 403-7.
8. Arnett FC, Edworthy SM, Bloch DA, McShance DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
9. Summary report CAP. Diagnostic Immunology S-A, Chicago: College of American Pathologists; 2001 p.14.
10. Tan EM, Feltkamp TE, Smolen JS, Butcher B, Dawkins R, Fritzler MJ, et al. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum 1997; 40: 1601-11.
11. Al-Jabri AA, Al Belushi MS, Nsanze H. Frequency and level of autoantibody in healthy adult Omanis. Ann Saudi Med 2003; 23: 372-5.
12. Baig MM, Shere SJ. Prevalance of autoantibodies in Saudi population. J Med 1989; 20: 286-90.
13. Azizah MR, Shahnaz M, Zulkifli MN, Azila MN, Nasuruddin BA. The occurrence of autoantibodies in sera of healthy pregnant women. Med J Malaysia 1997; 52: 8-11.
14. Bullock JY, Booth RJ, Wilson JD. Tissue antibodies in a healthy New Zealand population. N Z Med J 1979; 89: 11-3.
15. Butch AW. Dilution protocols for detection of hook effects/prozone phenomenon. Clin Chem 2000; 46: 1719-21.
16. Avaniss-Aghajani E, Berzon S, Sarkissian A. Clinical value of multiplexed bead-based immunoassays for detection of autoantibodies to nuclear antigens. Clin Vaccine Immunol 2007; 14: 505-9.